A Symphony of Sound Strategy
Staying true to their name, NeonMind Biosciences (CANADA: NEON) (U.S.: NMDBF) (EUROPE: 6UF) is committed to awaking vibrant change in patients’ psychological experiences, utilizing ...
Read MoreStaying true to their name, NeonMind Biosciences (CANADA: NEON) (U.S.: NMDBF) (EUROPE: 6UF) is committed to awaking vibrant change in patients’ psychological experiences, utilizing ...
Read MoreCompanies in the psychedelic sector are engaged in one common cause: utilizing new technologies, methods, and treatments to expedite the journey ...
Read MoreWe’re sure that you already know the health food industry has been a hot topic this ...
Read More[fusion_builder_container type=”flex” hundred_percent=”no” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_color=”” background_image=”” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” ...
Read MoreIronically known by the ticker “COOL” in Canada – Core One is anything but, as they remain on fire ...
Read MoreNo market catalysts in the world of fungi have been touted more than the forward-looking ones regarding the ...
Read MoreAs sustainable, animal–friendly, and environmentally conscious food companies surge in popularity this last year, it takes a little ...
Read MoreVancouver, B.C. – January 12, 2021: NeonMind Biosciences Inc. (CSE: NEON) (“NeonMind”), a psychedelic drug ...
Read MoreWe’ve been putting in long hours to understand, interpret, and communicate the intricacies of the ...
Read MoreRead on to find out 3 of the top IPOs to watch in Q4 2020… ...
Read MorePure Extracts Technologies Corp. has officially commenced trading on the Canadian Securities Exchange (CSE) as of November 5th, ...
Read MoreRecently, we’re seeing the resurgence of the drug in mainstream media for the first time since 1971, ...
Read MoreBeyond Meat was the hottest IPO of 2019, rising by 163% on the very first ...
Read MoreGet 30+ hours of analyst research directly in your inbox weekly. Sign-up today to stay on top of the market.